Global Typhoid Fever Vaccines Market Overview And Scope:
Global Typhoid Fever Vaccines Market Size was estimated at USD 225.95 million in 2022 and is projected to reach USD 334.69 million by 2028, exhibiting a CAGR of 6.77% during the forecast period.
The Global Typhoid Fever Vaccines Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Typhoid Fever Vaccines utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, PaxVax, Biomed, Prokarium, China National Biotec Group
Global Typhoid Fever Vaccines Market Segmentation
By Type, Typhoid Fever Vaccines market has been segmented into:Live Attenuated Vaccine
Conjugate Vaccine
Capsular Polysaccharide Vaccines
Others
By Application, Typhoid Fever Vaccines market has been segmented into:
Government Institution
Private Sector
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Typhoid Fever Vaccines market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Typhoid Fever Vaccines market.
Top Key Players Covered in Typhoid Fever Vaccines market are:
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
PaxVax
Biomed
Prokarium
China National Biotec Group
Objective to buy this Report:
1. Typhoid Fever Vaccines analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Typhoid Fever Vaccines market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Typhoid Fever Vaccines Market by Type
5.1 Typhoid Fever Vaccines Market Overview Snapshot and Growth Engine
5.2 Typhoid Fever Vaccines Market Overview
5.3 Live Attenuated Vaccine
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Live Attenuated Vaccine: Geographic Segmentation
5.4 Conjugate Vaccine
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Conjugate Vaccine: Geographic Segmentation
5.5 Capsular Polysaccharide Vaccines
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Capsular Polysaccharide Vaccines: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: Typhoid Fever Vaccines Market by Application
6.1 Typhoid Fever Vaccines Market Overview Snapshot and Growth Engine
6.2 Typhoid Fever Vaccines Market Overview
6.3 Government Institution
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Government Institution: Geographic Segmentation
6.4 Private Sector
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Private Sector: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Typhoid Fever Vaccines Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Typhoid Fever Vaccines Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Typhoid Fever Vaccines Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 SANOFI PASTEUR
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 GLAXOSMITHKLINE
7.4 BHARAT BIOTECH
7.5 PAXVAX
7.6 BIOMED
7.7 PROKARIUM
7.8 CHINA NATIONAL BIOTEC GROUP
Chapter 8: Global Typhoid Fever Vaccines Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Live Attenuated Vaccine
8.2.2 Conjugate Vaccine
8.2.3 Capsular Polysaccharide Vaccines
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Government Institution
8.3.2 Private Sector
Chapter 9: North America Typhoid Fever Vaccines Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Live Attenuated Vaccine
9.4.2 Conjugate Vaccine
9.4.3 Capsular Polysaccharide Vaccines
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Government Institution
9.5.2 Private Sector
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Typhoid Fever Vaccines Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Live Attenuated Vaccine
10.4.2 Conjugate Vaccine
10.4.3 Capsular Polysaccharide Vaccines
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Government Institution
10.5.2 Private Sector
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Typhoid Fever Vaccines Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Live Attenuated Vaccine
11.4.2 Conjugate Vaccine
11.4.3 Capsular Polysaccharide Vaccines
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Government Institution
11.5.2 Private Sector
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Typhoid Fever Vaccines Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Live Attenuated Vaccine
12.4.2 Conjugate Vaccine
12.4.3 Capsular Polysaccharide Vaccines
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Government Institution
12.5.2 Private Sector
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Typhoid Fever Vaccines Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Live Attenuated Vaccine
13.4.2 Conjugate Vaccine
13.4.3 Capsular Polysaccharide Vaccines
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Government Institution
13.5.2 Private Sector
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Typhoid Fever Vaccines Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Live Attenuated Vaccine
14.4.2 Conjugate Vaccine
14.4.3 Capsular Polysaccharide Vaccines
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Government Institution
14.5.2 Private Sector
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Typhoid Fever Vaccines Scope:
|
Report Data
|
Typhoid Fever Vaccines Market
|
|
Typhoid Fever Vaccines Market Size in 2025
|
USD XX million
|
|
Typhoid Fever Vaccines CAGR 2025 - 2032
|
XX%
|
|
Typhoid Fever Vaccines Base Year
|
2024
|
|
Typhoid Fever Vaccines Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, PaxVax, Biomed, Prokarium, China National Biotec Group.
|
|
Key Segments
|
By Type
Live Attenuated Vaccine
Conjugate Vaccine
Capsular Polysaccharide Vaccines
Others
By Applications
Government Institution
Private Sector
|
